<?xml version="1.0"?>
<rss version="2.0">
 <channel>
  <title>StreetInsider.com News Articles</title>
  <link>http://www.streetinsider.com</link>
  <description>Latest StreetInsider.com News Articles</description>
  <language>en-us</language>
  <copyright>Copyright 2026, StreetInsider.com</copyright>
  <managingEditor>rss@streetinsider.com (SI RSS)</managingEditor>
  <webMaster>rss@streetinsider.com (SI RSS)</webMaster>
  <lastBuildDate>Tue, 02 Jun 2026 12:05:00 -0400</lastBuildDate>
  <docs>http://blogs.law.harvard.edu/tech/rss</docs>
  <image>
   <url>http://www.streetinsider.com/images/rss_logo.gif</url>
   <title>StreetInsider.com News Articles</title>
   <link>http://www.streetinsider.com</link>
   <width>143</width>
   <height>28</height>
  </image>
  <skipHours>
   <hour>0</hour>
   <hour>1</hour>
   <hour>2</hour>
   <hour>3</hour>
   <hour>21</hour>
   <hour>22</hour>
   <hour>23</hour>
  </skipHours>
  <skipDays>
   <day>Saturday</day>
   <day>Sunday</day>
  </skipDays>
  <item>
   <title>AB Science : Stonegate Capital Partners updates its coverage of AB Science’s stock with a target price of EUR 4.25 per share</title>
   <link>http://www.streetinsider.com/Press+Releases/AB+Science+%3A+Stonegate+Capital+Partners+updates+its+coverage+of+AB+Science%E2%80%99s+stock+with+a+target+price+of+EUR+4.25+per+share/26590010.html</link>
   <description>
&lt;p align=&quot;right&quot;&gt;&lt;b&gt;PRESS RELEASE&lt;/b&gt;&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;&lt;b&gt;STONEGATE CAPITAL PARTNERS UPDATES ITS COVERAGE OF AB SCIENCE’S STOCK WITH A DISCOUNTED CASH FLOW VALUATION MID-POINT OF EUR 4.25 PER SHARE&lt;/b&gt;&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;&lt;i&gt;Paris, June 2&lt;/i&gt;&lt;i&gt;nd&lt;/i&gt;&lt;i&gt; , 2026, 6pm CET&lt;/i&gt;&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;&lt;b&gt;AB Science SA&lt;/b&gt; (Euronext - FR0010557264 - AB) announces that its stock continues to be covered by Stonegate Capital Partners, a leading independent US-based research and investor outreach firm, which has updated its coverage of the stock following the publication of AB Science’s full year 2025 results, supported by a discounted cash flow valuation with a mid-point of €4.25 per share (range</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/AB+Science+%3A+Stonegate+Capital+Partners+updates+its+coverage+of+AB+Science%E2%80%99s+stock+with+a+target+price+of+EUR+4.25+per+share/26590010.html</guid>
   <pubDate>Tue, 02 Jun 2026 12:05:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.50208788</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">AB</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00712912</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.09748147</category>
   	  </item>
  <item>
   <title>AB Science : Stonegate Capital Partners updates its coverage of AB Science’s stock with a target price of EUR 4.25 per share</title>
   <link>http://www.streetinsider.com/Press+Releases/AB+Science+%3A+Stonegate+Capital+Partners+updates+its+coverage+of+AB+Science%E2%80%99s+stock+with+a+target+price+of+EUR+4.25+per+share/26590010.html</link>
   <description>
&lt;p align=&quot;right&quot;&gt;&lt;b&gt;PRESS RELEASE&lt;/b&gt;&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;&lt;b&gt;STONEGATE CAPITAL PARTNERS UPDATES ITS COVERAGE OF AB SCIENCE’S STOCK WITH A DISCOUNTED CASH FLOW VALUATION MID-POINT OF EUR 4.25 PER SHARE&lt;/b&gt;&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;&lt;i&gt;Paris, June 2&lt;/i&gt;&lt;i&gt;nd&lt;/i&gt;&lt;i&gt; , 2026, 6pm CET&lt;/i&gt;&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;&lt;b&gt;AB Science SA&lt;/b&gt; (Euronext - FR0010557264 - AB) announces that its stock continues to be covered by Stonegate Capital Partners, a leading independent US-based research and investor outreach firm, which has updated its coverage of the stock following the publication of AB Science’s full year 2025 results, supported by a discounted cash flow valuation with a mid-point of €4.25 per share (range</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/AB+Science+%3A+Stonegate+Capital+Partners+updates+its+coverage+of+AB+Science%E2%80%99s+stock+with+a+target+price+of+EUR+4.25+per+share/26590010.html</guid>
   <pubDate>Tue, 02 Jun 2026 12:05:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.50208788</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">AB</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00712912</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.09748147</category>
   	  </item>
  <item>
   <title>AB Science : Stonegate Capital Partners updates its coverage of AB Science’s stock with a target price of EUR 4.25 per share</title>
   <link>http://www.streetinsider.com/Press+Releases/AB+Science+%3A+Stonegate+Capital+Partners+updates+its+coverage+of+AB+Science%E2%80%99s+stock+with+a+target+price+of+EUR+4.25+per+share/26590010.html</link>
   <description>
&lt;p align=&quot;right&quot;&gt;&lt;b&gt;PRESS RELEASE&lt;/b&gt;&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;&lt;b&gt;STONEGATE CAPITAL PARTNERS UPDATES ITS COVERAGE OF AB SCIENCE’S STOCK WITH A DISCOUNTED CASH FLOW VALUATION MID-POINT OF EUR 4.25 PER SHARE&lt;/b&gt;&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;&lt;i&gt;Paris, June 2&lt;/i&gt;&lt;i&gt;nd&lt;/i&gt;&lt;i&gt; , 2026, 6pm CET&lt;/i&gt;&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;&lt;b&gt;AB Science SA&lt;/b&gt; (Euronext - FR0010557264 - AB) announces that its stock continues to be covered by Stonegate Capital Partners, a leading independent US-based research and investor outreach firm, which has updated its coverage of the stock following the publication of AB Science’s full year 2025 results, supported by a discounted cash flow valuation with a mid-point of €4.25 per share (range</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/AB+Science+%3A+Stonegate+Capital+Partners+updates+its+coverage+of+AB+Science%E2%80%99s+stock+with+a+target+price+of+EUR+4.25+per+share/26590010.html</guid>
   <pubDate>Tue, 02 Jun 2026 12:05:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.50208788</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">AB</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00712912</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.09748147</category>
   	  </item>
  <item>
   <title>AB Science : Stonegate Capital Partners updates its coverage of AB Science’s stock with a target price of EUR 4.25 per share</title>
   <link>http://www.streetinsider.com/Press+Releases/AB+Science+%3A+Stonegate+Capital+Partners+updates+its+coverage+of+AB+Science%E2%80%99s+stock+with+a+target+price+of+EUR+4.25+per+share/26590010.html</link>
   <description>
&lt;p align=&quot;right&quot;&gt;&lt;b&gt;PRESS RELEASE&lt;/b&gt;&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;&lt;b&gt;STONEGATE CAPITAL PARTNERS UPDATES ITS COVERAGE OF AB SCIENCE’S STOCK WITH A DISCOUNTED CASH FLOW VALUATION MID-POINT OF EUR 4.25 PER SHARE&lt;/b&gt;&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;&lt;i&gt;Paris, June 2&lt;/i&gt;&lt;i&gt;nd&lt;/i&gt;&lt;i&gt; , 2026, 6pm CET&lt;/i&gt;&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;&lt;b&gt;AB Science SA&lt;/b&gt; (Euronext - FR0010557264 - AB) announces that its stock continues to be covered by Stonegate Capital Partners, a leading independent US-based research and investor outreach firm, which has updated its coverage of the stock following the publication of AB Science’s full year 2025 results, supported by a discounted cash flow valuation with a mid-point of €4.25 per share (range</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/AB+Science+%3A+Stonegate+Capital+Partners+updates+its+coverage+of+AB+Science%E2%80%99s+stock+with+a+target+price+of+EUR+4.25+per+share/26590010.html</guid>
   <pubDate>Tue, 02 Jun 2026 12:05:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.50208788</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">AB</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00712912</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.09748147</category>
   	  </item>
  <item>
   <title>AB Science : Stonegate Capital Partners updates its coverage of AB Science’s stock with a target price of EUR 4.25 per share</title>
   <link>http://www.streetinsider.com/Globe+Newswire/AB+Science+%3A+Stonegate+Capital+Partners+updates+its+coverage+of+AB+Science%E2%80%99s+stock+with+a+target+price+of+EUR+4.25+per+share/26590010.html</link>
   <description>
&lt;p align=&quot;right&quot;&gt;&lt;b&gt;PRESS RELEASE&lt;/b&gt;&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;&lt;b&gt;STONEGATE CAPITAL PARTNERS UPDATES ITS COVERAGE OF AB SCIENCE’S STOCK WITH A DISCOUNTED CASH FLOW VALUATION MID-POINT OF EUR 4.25 PER SHARE&lt;/b&gt;&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;&lt;i&gt;Paris, June 2&lt;/i&gt;&lt;i&gt;nd&lt;/i&gt;&lt;i&gt; , 2026, 6pm CET&lt;/i&gt;&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;&lt;b&gt;AB Science SA&lt;/b&gt; (Euronext - FR0010557264 - AB) announces that its stock continues to be covered by Stonegate Capital Partners, a leading independent US-based research and investor outreach firm, which has updated its coverage of the stock following the publication of AB Science’s full year 2025 results, supported by a discounted cash flow valuation with a mid-point of €4.25 per share (range</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/AB+Science+%3A+Stonegate+Capital+Partners+updates+its+coverage+of+AB+Science%E2%80%99s+stock+with+a+target+price+of+EUR+4.25+per+share/26590010.html</guid>
   <pubDate>Tue, 02 Jun 2026 12:05:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.50208788</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">AB</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00712912</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.09748147</category>
   	  </item>
  <item>
   <title>AB Science : Stonegate Capital Partners updates its coverage of AB Science’s stock with a target price of EUR 4.25 per share</title>
   <link>http://www.streetinsider.com/Globe+Newswire/AB+Science+%3A+Stonegate+Capital+Partners+updates+its+coverage+of+AB+Science%E2%80%99s+stock+with+a+target+price+of+EUR+4.25+per+share/26590010.html</link>
   <description>
&lt;p align=&quot;right&quot;&gt;&lt;b&gt;PRESS RELEASE&lt;/b&gt;&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;&lt;b&gt;STONEGATE CAPITAL PARTNERS UPDATES ITS COVERAGE OF AB SCIENCE’S STOCK WITH A DISCOUNTED CASH FLOW VALUATION MID-POINT OF EUR 4.25 PER SHARE&lt;/b&gt;&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;&lt;i&gt;Paris, June 2&lt;/i&gt;&lt;i&gt;nd&lt;/i&gt;&lt;i&gt; , 2026, 6pm CET&lt;/i&gt;&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;&lt;b&gt;AB Science SA&lt;/b&gt; (Euronext - FR0010557264 - AB) announces that its stock continues to be covered by Stonegate Capital Partners, a leading independent US-based research and investor outreach firm, which has updated its coverage of the stock following the publication of AB Science’s full year 2025 results, supported by a discounted cash flow valuation with a mid-point of €4.25 per share (range</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/AB+Science+%3A+Stonegate+Capital+Partners+updates+its+coverage+of+AB+Science%E2%80%99s+stock+with+a+target+price+of+EUR+4.25+per+share/26590010.html</guid>
   <pubDate>Tue, 02 Jun 2026 12:05:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.50208788</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">AB</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00712912</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.09748147</category>
   	  </item>
  <item>
   <title>AB Science : Stonegate Capital Partners updates its coverage of AB Science’s stock with a target price of EUR 4.25 per share</title>
   <link>http://www.streetinsider.com/Globe+Newswire/AB+Science+%3A+Stonegate+Capital+Partners+updates+its+coverage+of+AB+Science%E2%80%99s+stock+with+a+target+price+of+EUR+4.25+per+share/26590010.html</link>
   <description>
&lt;p align=&quot;right&quot;&gt;&lt;b&gt;PRESS RELEASE&lt;/b&gt;&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;&lt;b&gt;STONEGATE CAPITAL PARTNERS UPDATES ITS COVERAGE OF AB SCIENCE’S STOCK WITH A DISCOUNTED CASH FLOW VALUATION MID-POINT OF EUR 4.25 PER SHARE&lt;/b&gt;&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;&lt;i&gt;Paris, June 2&lt;/i&gt;&lt;i&gt;nd&lt;/i&gt;&lt;i&gt; , 2026, 6pm CET&lt;/i&gt;&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;&lt;b&gt;AB Science SA&lt;/b&gt; (Euronext - FR0010557264 - AB) announces that its stock continues to be covered by Stonegate Capital Partners, a leading independent US-based research and investor outreach firm, which has updated its coverage of the stock following the publication of AB Science’s full year 2025 results, supported by a discounted cash flow valuation with a mid-point of €4.25 per share (range</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/AB+Science+%3A+Stonegate+Capital+Partners+updates+its+coverage+of+AB+Science%E2%80%99s+stock+with+a+target+price+of+EUR+4.25+per+share/26590010.html</guid>
   <pubDate>Tue, 02 Jun 2026 12:05:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.50208788</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">AB</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00712912</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.09748147</category>
   	  </item>
  <item>
   <title>AB Science : Stonegate Capital Partners updates its coverage of AB Science’s stock with a target price of EUR 4.25 per share</title>
   <link>http://www.streetinsider.com/Globe+Newswire/AB+Science+%3A+Stonegate+Capital+Partners+updates+its+coverage+of+AB+Science%E2%80%99s+stock+with+a+target+price+of+EUR+4.25+per+share/26590010.html</link>
   <description>
&lt;p align=&quot;right&quot;&gt;&lt;b&gt;PRESS RELEASE&lt;/b&gt;&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;&lt;b&gt;STONEGATE CAPITAL PARTNERS UPDATES ITS COVERAGE OF AB SCIENCE’S STOCK WITH A DISCOUNTED CASH FLOW VALUATION MID-POINT OF EUR 4.25 PER SHARE&lt;/b&gt;&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;&lt;i&gt;Paris, June 2&lt;/i&gt;&lt;i&gt;nd&lt;/i&gt;&lt;i&gt; , 2026, 6pm CET&lt;/i&gt;&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;&lt;b&gt;AB Science SA&lt;/b&gt; (Euronext - FR0010557264 - AB) announces that its stock continues to be covered by Stonegate Capital Partners, a leading independent US-based research and investor outreach firm, which has updated its coverage of the stock following the publication of AB Science’s full year 2025 results, supported by a discounted cash flow valuation with a mid-point of €4.25 per share (range</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/AB+Science+%3A+Stonegate+Capital+Partners+updates+its+coverage+of+AB+Science%E2%80%99s+stock+with+a+target+price+of+EUR+4.25+per+share/26590010.html</guid>
   <pubDate>Tue, 02 Jun 2026 12:05:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.50208788</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">AB</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00712912</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.09748147</category>
   	  </item>
  <item>
   <title>AB Science announces that its stock continues to be covered by Maxim Group, with a target price of €4.00 per share</title>
   <link>http://www.streetinsider.com/Press+Releases/AB+Science+announces+that+its+stock+continues+to+be+covered+by+Maxim+Group%2C+with+a+target+price+of+%E2%82%AC4.00+per+share/26544411.html</link>
   <description>
&lt;p align=&quot;right&quot;&gt;&lt;b&gt;PRESS RELEASE&lt;/b&gt;&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;&lt;b&gt;FOLLOWING RELEASE OF FYE2025 RESULTS AND SECURING OF CLINICAL TRIAL INSURANCE POLICY, MAXIM GROUP REITERATES ITS BUY RECOMMENDATION ON AB SCIENCE’S STOCK WITH A TARGET PRICE OF EUR 4.0 PER SHARE&lt;/b&gt;&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;&lt;i&gt;Paris, May 25, 2026, 6pm CET&lt;/i&gt;&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;&lt;b&gt;AB Science SA&lt;/b&gt; (Euronext - FR0010557264 - AB) announces that its stock continues to be covered by Maxim Group, an independent US-based full-service investment bank, securities and wealth management firm, which has reiterated its Buy recommendation on the stock with a target price of €4.00 per share.&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;Maxim Group issued this recommendation</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/AB+Science+announces+that+its+stock+continues+to+be+covered+by+Maxim+Group%2C+with+a+target+price+of+%E2%82%AC4.00+per+share/26544411.html</guid>
   <pubDate>Mon, 25 May 2026 12:06:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.50208788</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">AB</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00712912</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.09748147</category>
   	  </item>
  <item>
   <title>AB Science announces that its stock continues to be covered by Maxim Group, with a target price of €4.00 per share</title>
   <link>http://www.streetinsider.com/Press+Releases/AB+Science+announces+that+its+stock+continues+to+be+covered+by+Maxim+Group%2C+with+a+target+price+of+%E2%82%AC4.00+per+share/26544411.html</link>
   <description>
&lt;p align=&quot;right&quot;&gt;&lt;b&gt;PRESS RELEASE&lt;/b&gt;&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;&lt;b&gt;FOLLOWING RELEASE OF FYE2025 RESULTS AND SECURING OF CLINICAL TRIAL INSURANCE POLICY, MAXIM GROUP REITERATES ITS BUY RECOMMENDATION ON AB SCIENCE’S STOCK WITH A TARGET PRICE OF EUR 4.0 PER SHARE&lt;/b&gt;&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;&lt;i&gt;Paris, May 25, 2026, 6pm CET&lt;/i&gt;&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;&lt;b&gt;AB Science SA&lt;/b&gt; (Euronext - FR0010557264 - AB) announces that its stock continues to be covered by Maxim Group, an independent US-based full-service investment bank, securities and wealth management firm, which has reiterated its Buy recommendation on the stock with a target price of €4.00 per share.&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;Maxim Group issued this recommendation</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/AB+Science+announces+that+its+stock+continues+to+be+covered+by+Maxim+Group%2C+with+a+target+price+of+%E2%82%AC4.00+per+share/26544411.html</guid>
   <pubDate>Mon, 25 May 2026 12:06:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.50208788</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">AB</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00712912</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.09748147</category>
   	  </item>
  <item>
   <title>AB Science announces that its stock continues to be covered by Maxim Group, with a target price of €4.00 per share</title>
   <link>http://www.streetinsider.com/Press+Releases/AB+Science+announces+that+its+stock+continues+to+be+covered+by+Maxim+Group%2C+with+a+target+price+of+%E2%82%AC4.00+per+share/26544411.html</link>
   <description>
&lt;p align=&quot;right&quot;&gt;&lt;b&gt;PRESS RELEASE&lt;/b&gt;&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;&lt;b&gt;FOLLOWING RELEASE OF FYE2025 RESULTS AND SECURING OF CLINICAL TRIAL INSURANCE POLICY, MAXIM GROUP REITERATES ITS BUY RECOMMENDATION ON AB SCIENCE’S STOCK WITH A TARGET PRICE OF EUR 4.0 PER SHARE&lt;/b&gt;&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;&lt;i&gt;Paris, May 25, 2026, 6pm CET&lt;/i&gt;&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;&lt;b&gt;AB Science SA&lt;/b&gt; (Euronext - FR0010557264 - AB) announces that its stock continues to be covered by Maxim Group, an independent US-based full-service investment bank, securities and wealth management firm, which has reiterated its Buy recommendation on the stock with a target price of €4.00 per share.&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;Maxim Group issued this recommendation</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/AB+Science+announces+that+its+stock+continues+to+be+covered+by+Maxim+Group%2C+with+a+target+price+of+%E2%82%AC4.00+per+share/26544411.html</guid>
   <pubDate>Mon, 25 May 2026 12:06:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.50208788</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">AB</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00712912</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.09748147</category>
   	  </item>
  <item>
   <title>AB Science announces that its stock continues to be covered by Maxim Group, with a target price of €4.00 per share</title>
   <link>http://www.streetinsider.com/Press+Releases/AB+Science+announces+that+its+stock+continues+to+be+covered+by+Maxim+Group%2C+with+a+target+price+of+%E2%82%AC4.00+per+share/26544411.html</link>
   <description>
&lt;p align=&quot;right&quot;&gt;&lt;b&gt;PRESS RELEASE&lt;/b&gt;&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;&lt;b&gt;FOLLOWING RELEASE OF FYE2025 RESULTS AND SECURING OF CLINICAL TRIAL INSURANCE POLICY, MAXIM GROUP REITERATES ITS BUY RECOMMENDATION ON AB SCIENCE’S STOCK WITH A TARGET PRICE OF EUR 4.0 PER SHARE&lt;/b&gt;&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;&lt;i&gt;Paris, May 25, 2026, 6pm CET&lt;/i&gt;&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;&lt;b&gt;AB Science SA&lt;/b&gt; (Euronext - FR0010557264 - AB) announces that its stock continues to be covered by Maxim Group, an independent US-based full-service investment bank, securities and wealth management firm, which has reiterated its Buy recommendation on the stock with a target price of €4.00 per share.&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;Maxim Group issued this recommendation</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/AB+Science+announces+that+its+stock+continues+to+be+covered+by+Maxim+Group%2C+with+a+target+price+of+%E2%82%AC4.00+per+share/26544411.html</guid>
   <pubDate>Mon, 25 May 2026 12:06:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.50208788</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">AB</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00712912</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.09748147</category>
   	  </item>
  <item>
   <title>AB Science announces that its stock continues to be covered by Maxim Group, with a target price of €4.00 per share</title>
   <link>http://www.streetinsider.com/Globe+Newswire/AB+Science+announces+that+its+stock+continues+to+be+covered+by+Maxim+Group%2C+with+a+target+price+of+%E2%82%AC4.00+per+share/26544411.html</link>
   <description>
&lt;p align=&quot;right&quot;&gt;&lt;b&gt;PRESS RELEASE&lt;/b&gt;&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;&lt;b&gt;FOLLOWING RELEASE OF FYE2025 RESULTS AND SECURING OF CLINICAL TRIAL INSURANCE POLICY, MAXIM GROUP REITERATES ITS BUY RECOMMENDATION ON AB SCIENCE’S STOCK WITH A TARGET PRICE OF EUR 4.0 PER SHARE&lt;/b&gt;&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;&lt;i&gt;Paris, May 25, 2026, 6pm CET&lt;/i&gt;&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;&lt;b&gt;AB Science SA&lt;/b&gt; (Euronext - FR0010557264 - AB) announces that its stock continues to be covered by Maxim Group, an independent US-based full-service investment bank, securities and wealth management firm, which has reiterated its Buy recommendation on the stock with a target price of €4.00 per share.&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;Maxim Group issued this recommendation</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/AB+Science+announces+that+its+stock+continues+to+be+covered+by+Maxim+Group%2C+with+a+target+price+of+%E2%82%AC4.00+per+share/26544411.html</guid>
   <pubDate>Mon, 25 May 2026 12:06:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.50208788</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">AB</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00712912</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.09748147</category>
   	  </item>
  <item>
   <title>AB Science announces that its stock continues to be covered by Maxim Group, with a target price of €4.00 per share</title>
   <link>http://www.streetinsider.com/Globe+Newswire/AB+Science+announces+that+its+stock+continues+to+be+covered+by+Maxim+Group%2C+with+a+target+price+of+%E2%82%AC4.00+per+share/26544411.html</link>
   <description>
&lt;p align=&quot;right&quot;&gt;&lt;b&gt;PRESS RELEASE&lt;/b&gt;&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;&lt;b&gt;FOLLOWING RELEASE OF FYE2025 RESULTS AND SECURING OF CLINICAL TRIAL INSURANCE POLICY, MAXIM GROUP REITERATES ITS BUY RECOMMENDATION ON AB SCIENCE’S STOCK WITH A TARGET PRICE OF EUR 4.0 PER SHARE&lt;/b&gt;&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;&lt;i&gt;Paris, May 25, 2026, 6pm CET&lt;/i&gt;&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;&lt;b&gt;AB Science SA&lt;/b&gt; (Euronext - FR0010557264 - AB) announces that its stock continues to be covered by Maxim Group, an independent US-based full-service investment bank, securities and wealth management firm, which has reiterated its Buy recommendation on the stock with a target price of €4.00 per share.&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;Maxim Group issued this recommendation</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/AB+Science+announces+that+its+stock+continues+to+be+covered+by+Maxim+Group%2C+with+a+target+price+of+%E2%82%AC4.00+per+share/26544411.html</guid>
   <pubDate>Mon, 25 May 2026 12:06:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.50208788</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">AB</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00712912</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.09748147</category>
   	  </item>
  <item>
   <title>AB Science announces that its stock continues to be covered by Maxim Group, with a target price of €4.00 per share</title>
   <link>http://www.streetinsider.com/Globe+Newswire/AB+Science+announces+that+its+stock+continues+to+be+covered+by+Maxim+Group%2C+with+a+target+price+of+%E2%82%AC4.00+per+share/26544411.html</link>
   <description>
&lt;p align=&quot;right&quot;&gt;&lt;b&gt;PRESS RELEASE&lt;/b&gt;&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;&lt;b&gt;FOLLOWING RELEASE OF FYE2025 RESULTS AND SECURING OF CLINICAL TRIAL INSURANCE POLICY, MAXIM GROUP REITERATES ITS BUY RECOMMENDATION ON AB SCIENCE’S STOCK WITH A TARGET PRICE OF EUR 4.0 PER SHARE&lt;/b&gt;&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;&lt;i&gt;Paris, May 25, 2026, 6pm CET&lt;/i&gt;&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;&lt;b&gt;AB Science SA&lt;/b&gt; (Euronext - FR0010557264 - AB) announces that its stock continues to be covered by Maxim Group, an independent US-based full-service investment bank, securities and wealth management firm, which has reiterated its Buy recommendation on the stock with a target price of €4.00 per share.&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;Maxim Group issued this recommendation</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/AB+Science+announces+that+its+stock+continues+to+be+covered+by+Maxim+Group%2C+with+a+target+price+of+%E2%82%AC4.00+per+share/26544411.html</guid>
   <pubDate>Mon, 25 May 2026 12:06:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.50208788</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">AB</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00712912</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.09748147</category>
   	  </item>
  <item>
   <title>AB Science announces that its stock continues to be covered by Maxim Group, with a target price of €4.00 per share</title>
   <link>http://www.streetinsider.com/Globe+Newswire/AB+Science+announces+that+its+stock+continues+to+be+covered+by+Maxim+Group%2C+with+a+target+price+of+%E2%82%AC4.00+per+share/26544411.html</link>
   <description>
&lt;p align=&quot;right&quot;&gt;&lt;b&gt;PRESS RELEASE&lt;/b&gt;&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;&lt;b&gt;FOLLOWING RELEASE OF FYE2025 RESULTS AND SECURING OF CLINICAL TRIAL INSURANCE POLICY, MAXIM GROUP REITERATES ITS BUY RECOMMENDATION ON AB SCIENCE’S STOCK WITH A TARGET PRICE OF EUR 4.0 PER SHARE&lt;/b&gt;&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;&lt;i&gt;Paris, May 25, 2026, 6pm CET&lt;/i&gt;&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;&lt;b&gt;AB Science SA&lt;/b&gt; (Euronext - FR0010557264 - AB) announces that its stock continues to be covered by Maxim Group, an independent US-based full-service investment bank, securities and wealth management firm, which has reiterated its Buy recommendation on the stock with a target price of €4.00 per share.&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;Maxim Group issued this recommendation</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/AB+Science+announces+that+its+stock+continues+to+be+covered+by+Maxim+Group%2C+with+a+target+price+of+%E2%82%AC4.00+per+share/26544411.html</guid>
   <pubDate>Mon, 25 May 2026 12:06:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.50208788</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">AB</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00712912</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.09748147</category>
   	  </item>
  <item>
   <title>Form  4          ALLIANCEBERNSTEIN HOLDIN  For: May 20  Filed by: Holley Bruce M</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++ALLIANCEBERNSTEIN+HOLDIN++For%3A+May+20++Filed+by%3A+Holley+Bruce+M/26542960.html</link>
   <description>si-local-file:///var/storage/secattach/20260522/26542960.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++ALLIANCEBERNSTEIN+HOLDIN++For%3A+May+20++Filed+by%3A+Holley+Bruce+M/26542960.html</guid>
   <pubDate>Fri, 22 May 2026 17:28:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">AB</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00030642</category>
   	  </item>
  <item>
   <title>Form  4          ALLIANCEBERNSTEIN HOLDIN  For: May 20  Filed by: Holley Bruce M</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++ALLIANCEBERNSTEIN+HOLDIN++For%3A+May+20++Filed+by%3A+Holley+Bruce+M/26542960.html</link>
   <description>si-local-file:///var/storage/secattach/20260522/26542960.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++ALLIANCEBERNSTEIN+HOLDIN++For%3A+May+20++Filed+by%3A+Holley+Bruce+M/26542960.html</guid>
   <pubDate>Fri, 22 May 2026 17:28:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">AB</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00030642</category>
   	  </item>
  <item>
   <title>Form  4          ALLIANCEBERNSTEIN HOLDIN  For: May 20  Filed by: Stonehill Charles G.T.</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++ALLIANCEBERNSTEIN+HOLDIN++For%3A+May+20++Filed+by%3A+Stonehill+Charles+G.T./26542565.html</link>
   <description>si-local-file:///var/storage/secattach/20260522/26542565.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++ALLIANCEBERNSTEIN+HOLDIN++For%3A+May+20++Filed+by%3A+Stonehill+Charles+G.T./26542565.html</guid>
   <pubDate>Fri, 22 May 2026 16:48:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">AB</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00030642</category>
   	  </item>
  <item>
   <title>Form  4          ALLIANCEBERNSTEIN HOLDIN  For: May 20  Filed by: Stonehill Charles G.T.</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++ALLIANCEBERNSTEIN+HOLDIN++For%3A+May+20++Filed+by%3A+Stonehill+Charles+G.T./26542565.html</link>
   <description>si-local-file:///var/storage/secattach/20260522/26542565.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++ALLIANCEBERNSTEIN+HOLDIN++For%3A+May+20++Filed+by%3A+Stonehill+Charles+G.T./26542565.html</guid>
   <pubDate>Fri, 22 May 2026 16:48:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">AB</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00030642</category>
   	  </item>
  <item>
   <title>Form  4          ALLIANCEBERNSTEIN HOLDIN  For: May 20  Filed by: Kaye Daniel G</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++ALLIANCEBERNSTEIN+HOLDIN++For%3A+May+20++Filed+by%3A+Kaye+Daniel+G/26542536.html</link>
   <description>si-local-file:///var/storage/secattach/20260522/26542536.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++ALLIANCEBERNSTEIN+HOLDIN++For%3A+May+20++Filed+by%3A+Kaye+Daniel+G/26542536.html</guid>
   <pubDate>Fri, 22 May 2026 16:45:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">AB</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00030642</category>
   	  </item>
  <item>
   <title>Form  4          ALLIANCEBERNSTEIN HOLDIN  For: May 20  Filed by: Kaye Daniel G</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++ALLIANCEBERNSTEIN+HOLDIN++For%3A+May+20++Filed+by%3A+Kaye+Daniel+G/26542536.html</link>
   <description>si-local-file:///var/storage/secattach/20260522/26542536.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++ALLIANCEBERNSTEIN+HOLDIN++For%3A+May+20++Filed+by%3A+Kaye+Daniel+G/26542536.html</guid>
   <pubDate>Fri, 22 May 2026 16:45:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">AB</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00030642</category>
   	  </item>
  <item>
   <title>Form  4          ALLIANCEBERNSTEIN HOLDIN  For: May 20  Filed by: Narayandas Das</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++ALLIANCEBERNSTEIN+HOLDIN++For%3A+May+20++Filed+by%3A+Narayandas+Das/26542510.html</link>
   <description>si-local-file:///var/storage/secattach/20260522/26542510.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++ALLIANCEBERNSTEIN+HOLDIN++For%3A+May+20++Filed+by%3A+Narayandas+Das/26542510.html</guid>
   <pubDate>Fri, 22 May 2026 16:43:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">AB</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00030642</category>
   	  </item>
  <item>
   <title>Form  4          ALLIANCEBERNSTEIN HOLDIN  For: May 20  Filed by: Narayandas Das</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++ALLIANCEBERNSTEIN+HOLDIN++For%3A+May+20++Filed+by%3A+Narayandas+Das/26542510.html</link>
   <description>si-local-file:///var/storage/secattach/20260522/26542510.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++ALLIANCEBERNSTEIN+HOLDIN++For%3A+May+20++Filed+by%3A+Narayandas+Das/26542510.html</guid>
   <pubDate>Fri, 22 May 2026 16:43:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">AB</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00030642</category>
   	  </item>
  <item>
   <title>Form  4          ALLIANCEBERNSTEIN HOLDIN  For: May 20  Filed by: Walthall Todd</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++ALLIANCEBERNSTEIN+HOLDIN++For%3A+May+20++Filed+by%3A+Walthall+Todd/26542477.html</link>
   <description>si-local-file:///var/storage/secattach/20260522/26542477.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++ALLIANCEBERNSTEIN+HOLDIN++For%3A+May+20++Filed+by%3A+Walthall+Todd/26542477.html</guid>
   <pubDate>Fri, 22 May 2026 16:39:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">AB</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00030642</category>
   	  </item>
 </channel>
</rss>
